Search Results - "Seryakov, Aleksander"

Clinically relevant fusion oncogenes: detection and practical implications by Sorokin, Maksim, Rabushko, Elizaveta, Rozenberg, Julian Markovich, Mohammad, Tharaa, Seryakov, Aleksander, Sekacheva, Marina, Buzdin, Anton

“…Mechanistically, chimeric genes result from DNA rearrangements and include parts of preexisting normal genes combined at the genomic junction site. Some…”
Get full text

Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways by Zolotovskaia, Marianna A., Modestov, Alexander A., Suntsova, Maria V., Rachkova, Anastasia A., Koroleva, Elena V., Poddubskaya, Elena V., Sekacheva, Marina I., Tkachev, Victor S., Garazha, Andrew V., Glusker, Alexander A., Seryakov, Aleksander P., Vladimirova, Uliana S., Rumiantsev, Pavel O., Moisseev, Aleksey A., Zharkov, Dmitry O., Kuzmin, Denis V., Zhao, Xiaowen, Prassolov, Vladimir S., Shegay, Petr V., Li, Xinmin, Steinbichler, Teresa B., Kim, Ella, Sorokin, Maxim I., Wang, Ye, Buzdin, Anton A.

“…DNA repair mechanisms keep genome integrity and limit tumor-associated alterations and heterogeneity, but on the other hand they promote tumor survival after…”
Get full text

Large-scale assessment of pros and cons of autopsy-derived or tumor-matched tissues as the norms for gene expression analysis in cancers by Sorokin, Maksim, Buzdin, Anton A., Guryanova, Anastasia, Efimov, Victor, Suntsova, Maria V., Zolotovskaia, Marianna A., Koroleva, Elena V., Sekacheva, Marina I., Tkachev, Victor S., Garazha, Andrew, Kremenchutckaya, Kristina, Drobyshev, Aleksey, Seryakov, Aleksander, Gudkov, Alexander, Alekseenko, Irina V., Rakitina, Olga, Kostina, Maria B., Vladimirova, Uliana, Moisseev, Aleksey, Bulgin, Dmitry, Radomskaya, Elena, Shestakov, Viktor, Baklaushev, Vladimir P., Prassolov, Vladimir, Shegay, Petr V., Li, Xinmin, Poddubskaya, Elena V., Gaifullin, Nurshat

“…Normal tissues are essential for studying disease-specific differential gene expression. However, healthy human controls are typically available only in…”
Get full text

Bioinformatic and clinical experimental assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new combined and individual survival biomarkers outperforming MGMT promoter methylation by Modestov, Alexander, Zolotovskaia, Marianna, Suntsova, Maria, Zakharova, Galina, Seryakov, Aleksander, Jovcevska, Ivana, Mlakar, Jernej, Poddubskaya, Elena, Moisseev, Aleksey, Vykhodtsev, Grigory, Roumiantsev, Sergey, Sorokin, Maksim, Tkachev, Victor, Simonov, Aleksander, Buzdin, Anton

“…Background: Glioblastoma (GBM) is the most aggressive and lethal central nervous system (CNS) tumor. The treatment strategy is mainly surgery and/or radiation…”
Get full text

Bioinformatic and clinical experimental assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new combined and individual survival biomarkers outperforming promoter methylation by Alexander Modestov, Marianna Zolotovskaia, Maria Suntsova, Galina Zakharova, Aleksander Seryakov, Ivana Jovcevska, Jernej Mlakar, Elena Poddubskaya, Aleksey Moisseev, Grigory Vykhodtsev, Sergey Roumiantsev, Maksim Sorokin, Victor Tkachev, Aleksander Simonov, Anton Buzdin

“…Background: Glioblastoma (GBM) is the most aggressive and lethal central nervous system (CNS) tumor. The treatment strategy is mainly surgery and/or radiation…”
Get full text